Company intelligence
Johnson & Johnson Innovative Medicine
About Johnson & Johnson Innovative Medicine
At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK
Verified activity
Signals from Johnson & Johnson Innovative Medicine
28 published signals
Presence & Recognition
Johnson & Johnson Innovative Medicine reported on the crisis management side of the evacuation in the French town of Le Porge.
Reported by Hannah Lennon
People
Johnson & Johnson Innovative Medicine is hiring a senior scientist to join a team and participate in a journey of innovation.
Reported by Mark Burcin, Ph.D.
Presence & Recognition
Johnson & Johnson Innovative Medicine teams will be attending the 2026 Psych Congress Annual Meeting in New Orleans, sharing 24 abstracts on bipolar mania, bipolar depression, major depressive disorder, treatment-resistant depression, and schizophrenia.
Reported by Leighann Forbes
Presence & Recognition
Johnson & Johnson Innovative Medicine joined multidisciplinary conversations on how to accelerate the uptake of advanced therapies in Europe at Phacilitate Advanced Therapies Europe #ATE26
Reported by Ingrid Marchal-Gérez, PhD, MBA
Presence & Recognition
Johnson & Johnson Innovative Medicine employee James Widener is speaking at the Patient Pathways Congress in Philadelphia.
Reported by James Widener, MBA, MHCI
Presence & Recognition
Johnson & Johnson Innovative Medicine employee Patrick Schuler posted an activity about the company.
Reported by Patrick Schuler
Presence & Recognition
Johnson & Johnson Innovative Medicine is attending the Dutch Medicines Days in Leiden on 8 October 2026.
Reported by Diana van der Graaf-Harris, PhD
Presence & Recognition
Johnson & Johnson Innovative Medicine participated in the EFMC2026 conference to discuss the discovery of JNJ-9676 and connect with José Enrique Gómez.
Reported by Santiago Cañellas, PhD
Presence & Recognition
Johnson & Johnson Innovative Medicine reflected on the passing of Dr. Robert Kyle, widely known as the Father of Multiple Myeloma.
Reported by Mark Wildgust
Presence & Recognition
Johnson & Johnson Innovative Medicine announced that submissions for the 2027 US Connect close tonight.
Reported by George Stuts
People
Johnson & Johnson Innovative Medicine promoted Dhruv Shah to IT Sr. Manager, Patient Experience.
Reported by Dhruv Shah
Presence & Recognition
Johnson & Johnson Innovative Medicine was named a finalist for the 2026 SCRS Eagle Award
Reported by Channia L. Holt
Presence & Recognition
Johnson & Johnson Innovative Medicine has been named as one of 5 finalists for the SCRS Eagle Award
Reported by Terttu Haring
People
Johnson & Johnson Innovative Medicine is announcing applications for the 2027 Advanced Pharmacy Practice Experience (APPE) Rotational Program for 4th-year pharmacy students.
Reported by Eunice Ofori Artis
Presence & Recognition
Johnson & Johnson Innovative Medicine is hosting an upcoming Global Oncology Summer Internship Program Information Session on September 24th, 2026, featuring a live Q&A session and mentorship opportunities.
Reported by Eunice Ofori Artis
Presence & Recognition
Johnson & Johnson Innovative Medicine announced that the deadline for paper submissions for PHUSE US Connect 2027 is September 4.
Reported by George Stuts
People
Johnson & Johnson Innovative Medicine appointed Tara Muzsi as President and U.S. Immunology.
Reported by Tara Muzsi
Presence & Recognition
Johnson & Johnson Innovative Medicine is seeking applications for the QuickFire Challenge for novel approaches to oral peptide delivery.
Reported by Ralf Angermund
People
Johnson & Johnson Innovative Medicine hired Dennis Sholler as an Associate Medical Director in US Medical Affairs.
Reported by Dennis Sholler
Research & Knowledge
Johnson & Johnson Innovative Medicine notes that China's EUV technology is at a similar stage to ASML in 2004.
Reported by Tobias Kuners of Koenders, CSCP
Presence & Recognition
Johnson & Johnson Innovative Medicine announced a three-part workshop on clinical trials on Wednesday, September 9, 2026, in London.
Reported by Ian Warden
Presence & Recognition
Johnson & Johnson Innovative Medicine employee Hemal Mehta will speak at the 2026 Combination Products Summit Workshop on November 16, 2026, exploring hot topics for combination products.
Reported by Hemal Mehta
Presence & Recognition
Johnson & Johnson Innovative Medicine hosted Night One of Effective Selling at Bentley University.
Reported by Zev D. Young, MS
People
Johnson & Johnson Innovative Medicine appointed Dr Bhavini Patel as Pre-Approval Access Study Responsible Physician, Global Medical Affairs Leader in Oncology.
Reported by Dr Bhavini Patel